Abstract
Background The COVID-19 pandemic precipitated an entirely virtual 2020-2021 residency application cycle. With many specialties continuing virtual interviews, it remains essential to evaluate all stakeholders perspectives.
Objective This study aimed to evaluate applicants’ perspectives on the completely virtual 2020-2021 Match.
Methods An online survey utilizing Likert scale and free response questions was distributed to residency applicants in 2021 post-Match to query their perspectives on the virtual application cycle.
Results Participants (n=158/2811, 5% estimated response rate) represented 24 states and applied to 31 specialties. Most were satisfied with their Match experience (73.1%) and thought virtual interviews should continue (68.6%). However, applicants felt that the virtual setting permitted interview hoarding (73.9%) and that their medical school did not provide adequate electronic equipment (66.1%). Applicants found Twitter (78.4%) and Instagram (69.1%) to be helpful social media platforms for evaluating fit. While many applicants (56.9%) did not support application limits, most supported interview limits (62.7%) and preference signaling mechanisms (59.7%). Free responses data elucidated applicants’ views on how the virtual Match impacted financial access, evaluation of program culture, and the future of residency interviews.
Conclusions Our study highlights that, across geography and specialty, many applicants support virtual interviews continuing. It also offers insight into how medical schools and residency programs can support applicants in the virtual environment. Additionally, the virtual setting provides an opportunity to evaluate mechanisms for addressing congestion within the Match, with most applicants supporting interview caps and preference signaling.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB #210572 "COVID Effects on Residency Applications" was approved for exemption status on 04/22/2021 by the Vanderbilt Human Research Protections Program - HRPP.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Prior Presentations This work will be presented virtually as a poster at the American Medical Student Association’s 72nd Annual Convention in April 2022.
Disclaimer No direct funding was provided for this study. The authors have no financial interests to declare in relation to the content of this article.
Revised to be more concise and focused on significant results
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
